Denteric
PrivateLast Round
Series A
Extension
Jan 15, 2025
Total Funding Raised
$19.66M
Company Overview
Denteric operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Series A Extension round in January 2025.
Denteric is a biotechnology company that develops vaccines and immunotherapies targeting Porphyromonas gingivalis to treat severe periodontal disease and associated chronic inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Denteric Comparables
Compare Denteric with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProEncia Biotechnology | 78% | |
| Lighthouse Pharmaceuticals | 78% | |
| Dexcel Pharma | 67% |
For institutional investors. Book with your work email.
Denteric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 15, 2025 | ||||
| Grant | Aug 2, 2024 | ||||
| Grant | Jul 24, 2022 | ||||
| Grant | Jul 20, 2022 | ||||
| Series A | Sep 26, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Denteric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| Australian Government Department of Industry, Science and Resources | Grant |
| Brandon Capital | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2025
Grew 60% QoQ, from 5 to 8 employees.
- Jan 15, 2025
$7.35M round with participation from Brandon Capital and CSL Ltd.
For institutional investors. Book with your work email.
Denteric Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Denteric's valuation, stock price, and market status.
Is Denteric a public or private company?
Denteric is a private company.
What is the current stock price of Denteric?
Denteric is a private company, so its shares have no public market price. Caplight tracks Denteric's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Denteric worth (valuation)?
Valuation information for Denteric is not publicly available.
Can I buy Denteric stock?
Denteric shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Denteric's last funding round?
Denteric's most recent funding round was Series A Extension on January 15, 2025.
Who are the main investors in Denteric?
Key investors in Denteric include Brandon Capital.
Will Denteric IPO soon?
No public IPO plans have been announced for Denteric.
How can I track Denteric secondary market activity?
Caplight tracks bids, offers, and trades in Denteric's shares on secondary markets.